Steris plc consensus stays positive, shares supported by buy ratings
25.06.2026 - 20:57:29 | ad-hoc-news.de
By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-25, 20:56.
Steris plc (IE00BFY8C754) continues to trade on the NYSE with a constructive analyst backdrop. According to current consensus data, most covering houses rate the shares Buy and see further upside over the next 12 months. Analyst overview on Investing.com
What the analysts are saying
Recent figures from Investing.com show that seven analysts currently cover Steris, with a consensus recommendation of Buy based on their ratings distribution. Consensus breakdown Six of these analysts advise buying the stock, while two recommend holding and none advise selling at this stage.
The same compilation reports an average 12-month price target of 256.86 US dollars for Steris shares, with individual targets ranging from 225 to 280 dollars per share. Target range and estimates For orientation, the shares recently changed hands around the low 210-dollar range in NYSE trading, indicating analysts still model a double-digit percentage upside from current levels. Latest STE quote on MarketBeat
Recent performance and growth profile
MarketBeat data place the Steris share price recently at roughly 212 dollars, after trading in a 1-day range between about 208 and 215 dollars on the NYSE. Intraday trading range Over the past 50 days, the trading range has stretched roughly from 199 to 226 dollars, illustrating moderate volatility typical for established healthcare equipment names.
Zacks currently assigns Steris a Rank #3 (Hold), but highlights the company as a solid growth story with a composite VGM Score of B, reflecting favorable growth and quality metrics in their framework. Zacks commentary on Steris In May 2026, Steris also reported full-year fiscal 2026 revenue growth of 9 percent from continuing operations and constant currency organic growth of 7 percent, underlining the structural demand for its infection-prevention solutions. Fiscal 2026 results release
All news and data on the Steris plc shares
Further company announcements, regulatory filings and price data on Steris plc are available in the dedicated topic area and on the official Investor Relations page.
The business behind the stock
Steris generates its revenue primarily with infection-prevention and sterilization products and services for hospitals, pharmaceutical manufacturers and research facilities worldwide. Capital.com company profile A core offering is low-temperature sterilization systems and surgical equipment, complemented by consumables and service contracts that generate recurring revenue and underpin the relatively resilient earnings profile.
Where the stock trades today
The Steris plc shares (IE00BFY8C754) trade on the NYSE under the ticker STE and recently changed hands at around 212 US dollars as of 2026-06-25, 16:00 (Eastern time).
Key data on the Steris plc shares
- Company: STERIS plc
- ISIN: IE00BFY8C754
- WKN: A14PQV
- Ticker: STE
- Trading venue: NYSE
- Price (as of 2026-06-25, 16:00): 212.00 USD
- Market cap: 21.5 billion USD (as of 2026-06-25)
- Sector / industry: Health Care Equipment & Supplies
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article is for informational purposes only and does not constitute investment advice, an offer or a solicitation to buy or sell any financial instrument. Investors should conduct their own research and, where appropriate, consult a qualified financial adviser before making investment decisions.
